A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IMT / L-3-iodo-alpha-methyl tyrosine

[Related PubMed/MEDLINE]
Total Number of Papers: 25
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IMT  (>> Co-occurring Abbreviation)
Long Form:   L-3-iodo-alpha-methyl tyrosine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2010 Stimulation of 125I-3-iodo-alpha-methyl-L-tyrosine uptake in Chinese hamster ovary (CHO-K1) cells by tyrosine esters. LAT1
2008 Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas. TBR
2006 [The usefulness of fused MRI and SPECT images for the voxel positioning in proton magnetic resonance spectroscopy and planning the biopsy of brain tumors: presentation of the method]. ---
2005 Characterization of (123)I-iodo-alpha-methyltyrosine transport in rat lymphoma cells. ---
2005 Recurrent cerebral gliomas in MRI and Iodine-123[corrected]-alpha-methyl-tyrosine SPECT: the use of digitally fused images. ---
2005 Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. CT, MET-PET, MRI, SPECT
2005 Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours. PNET
2004 Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas. MRI, PET, SPECT
2004 Renal accumulation and excretion of radioiodinated 3-iodo-alpha-methyl-L-tyrosine. RPTEC
10  2002 Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. SPET
11  2002 Comparison of [18F]FDG-PET and L-3[123I]-iodo-alpha-methyl tyrosine (I-123 IMT)-SPECT in primary lung cancer. ---
12  2002 I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours. ---
13  2002 Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile. FDG, PET, SPET, SUVs
14  2000 Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. SPECT
15  2000 [The role of L-3-I-123-iodine-alpha-methyltyrosine SPECT in cerebral gliomas]. SPECT
16  1998 Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. ---
17  1998 Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors. ---
18  1998 High amino acid uptake in a low-grade desmoplastic infantile ganglioglioma in a 14-year-old patient. DIG, MRI, SPECT
19  1998 Iodine-123 alpha-methyl-l-tyrosine single-photon emission tomography for the visualization of head and neck squamous cell carcinomas. SPET
20  1997 Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine. SPET
21  1996 Influence of size of regions of interest on the measurement of uptake of 123I-alpha-methyl tyrosine by brain tumours. ROIs
22  1996 Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions. SPET
23  1994 Uptake of radiolabelled tyrosine and iodo-methyl tyrosine in experimental rat tumours: influence of blood flow and tumour growth rate. PET, Tyr
24  1993 Uptake and distribution of L-3-[I-125] iodo-alpha-methyl tyrosine in experimental rat tumours: comparison with blood flow and growth rate. PET
25  1982 Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results. ES